Search Protocols under revision. Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupHematologic Diseases (ped.)DiseaseHemophagocytic LymphohistiocytosisSubgroupICD10D76.1MeSHLymphohistiocytosis, HemophagocyticSequencePAED ETOP150/DEXA10, HLH, C1 (PID665) -|- C2 (PID666) -|- C3+ (PID667)Antineoplastic therapySubstanceDexamethasoneEtoposideMethotrexateSubstanceDexamethasoneEtoposideMethotrexateSubstanceDexamethasoneEtoposideMethotrexateSubstanceDexamethasoneEtoposideMethotrexateNo. Substances12 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSubstanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSubstanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSubstanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronNo. Substances1345Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseInductionMaintenanceTherapy intentioncurativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorEhl SDiseaseHämophagozytische LymphohistiozytoseHämophagozytische Lymphohistiozytose des KindesOriginCenter for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, GermanyCenter for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany, HLH-94Protocols in Revision 4 protocols foundPAED Etoposide 150 / Dexamethasone (5 / 2.5 / 1.25), Hemophagocytic Lymphohistiocytosis, cycle 2 (PID666 V1.0)PAED Etoposide 150 / Dexamethasone 10, Hemophagocytic Lymphohistiocytosis, Cycle 1 (PID665 V1.0)PAED Etoposide 150 / Dexamethasone 10, Hemophagocytic Lymphohistiocytosis, Cycle 3+ (PID667 V1.0)PAED Methotrexate 12, Hemophagocytic Lymphohistiocytosis (PID672 V1.2)
